NO164097B - Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater. Download PDF

Info

Publication number
NO164097B
NO164097B NO851695A NO851695A NO164097B NO 164097 B NO164097 B NO 164097B NO 851695 A NO851695 A NO 851695A NO 851695 A NO851695 A NO 851695A NO 164097 B NO164097 B NO 164097B
Authority
NO
Norway
Prior art keywords
insulation
layer
insulations
track
tape
Prior art date
Application number
NO851695A
Other languages
English (en)
Other versions
NO851695L (no
NO164097C (no
Inventor
Lawrence Alan Reiter
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO851695L publication Critical patent/NO851695L/no
Publication of NO164097B publication Critical patent/NO164097B/no
Publication of NO164097C publication Critical patent/NO164097C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/28—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/04—Saturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/175—Saturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/227—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C07C57/60—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Description

Fremgangsmåte for isolering av staver eller spoler for høyspennings-statorviklinger.
Den foreliggende oppfinnelse vedrorer en fremgangsmåte for isolering av staver eller spoler i hoyspenningsstatorviklinger som såvel i spordelen som i viklingshodedelen er forsynt med båndisolasjon.
Av hoyspennings-statorviklinger forlanges en korrekt dimen-sjonert, tett isolasjon med stor elektrisk fasthet i spordelen. Til boyleforbindelsene for hodedelene på begge sider stilles vanligvis mindre strenge krav i så henseende. Det er kjent to fremgangsmåter for fremstilling av slike isolasjoner.
Ifolge den ene anbringes den i tallrike lag overlappende påviklede isolasjon gjennomgående og på samme måte i spordelen som i hodedelen. Om onsket, kan lagantallet og dermed isola-sjonens tykkelse gjores forskjellig for viklehodet og spordelen. Denne isolasjonstype kalles en likeformet, gjennomgående viklet isolasjon.
I det annet tilfelle anbringes spordelens og boylens isolasjoner hver for seg, og det kan benyttes forskjellige isolasjonsmateri-aler eller anbringelsesmetoder for de to deler. Det er således meget alminnelig å vikle en passende folie i en bred bane på spordelens lederbunt og presse den således dannede hylse fast under trykk- og eventuelt varmepåvirkning. For hodedelene kan det på grunn av boylens krumning bare benyttes båndisolasjon.
En således fremstilt isolasjon betegnes som ikke likeformet (diskontinuerlig) isolasjon. For ikke å forringe den elektriske sikkerhet på grunn av skjotene mellom spor- og boyleisolasjon, er det vanlig å gjore spordelens isolasjon lengre og påforé
den et godt stykke over statorens jerndel. På den koniske avslutning av spordelens isolasjon vikles så hodets båndisolasjon.
Et formål med den foreliggende oppfinnelse er å tilveiebringe
en hoy elektrisk fasthet i overgangen mellom spordelens og hodedelens isolasjon.
Dette oppnås ifolge oppfinnelsen ved at vekselvis er lederbuntens spordel henholdsvis hodedel omviklet med et sjikt av en adskilt båndisolasjon for innbyrdes forskyvning av overgangsstedet mellom de to isolasjoner fra sjikt til sjikt.
På denne måte vil det ved anbringelsen av isolasjonen på staven hhv. spolen overhodet ikke oppstå noe egentlig skjotested mellom de to isolasjoner, men hele isolasjonen forloper praktisk talt likeformet og kontinuerlig. Begge isolasjoner anbringes med en viss overdekking av sjiktene.
Oppfinnelsen skal beskrives nærmere under henvisning til tegningen, hvorpå figuren viser en del av en stav for en statorvikling i lengdesnitt. Stavens isolasjon utfores ifolge oppfinnelsen som folger:
Statorplatenes ende er antydet med b, for at den viklede
stavens stilling i forhold til statoren skal fremgå klart. På lederbunten a vikles forst et lag av et isolasjonsbånd av en eller annen isolasjon frem til det omtrentlige sted hvor overgangen fra den ene isolasjon til den annen skal opprettes, forst f.eks. laget n^ for sporisolasjonen. For bedre oversiktlighets skyld er båndets vindinger her vist kant i kant og ikke overlappende slik det er vanlig å legge dem. Til laget n^ slutter seg det nederste lag c, for boyleisolasjonen. Over dette anbringes lag c ? for bbyleisolasjonen og i tilslutning lag for spordelens isolasjon. På lignende måte anbringes derefter ytterligere lag n^, n^ m.v. for sporisolasjonen og tilsvarende lag c^/ c. m.v. for boyleisolasjonen vekselvis på staven inntil den onskede isolasjonstykkelse er oppnådd. Det må bare påaktes at skjotestedene mellom sporisolasjonens lag og de tilsvarende lag for boyleisolasjonen blir beliggende innenfor området for overgangen. Selvsagt er det også mulig å begynne med samme del av isolasjonen ved hvert nytt båndlag, dvs. å begynne enten med sporisolasjonen eller boyleisolasjonen, i stedet for å skifte som omtalt.
Som det vil fremgå av figuren, kan lagskjotene for de to isolasjoner forskyves i lengderetning fra lag til lag ved anbringelsen av isolasjonsbåndet. På denne måte oppnås enda storre elektrisk fasthet på overgangsstedet mellom de to isolasjoner, og ved bruk av bånd med forskjellig tykkelse for de to isolasjoner fås en jevnere overgang, dvs. man unngår praktisk talt utbukt-ning av isolasjonen på overgangsstedet. Ved bruk av forskjelligartede båndisolasjoner med forskjellig tykkelse for spor- og boyledelen kan det også tilveiebringes en utjevning uten ulemper for den elektriske fasthet på overgangen ved anbringelse av et storre antall lag på den side hvor båndet er tynnere og ved å
la to eller flere lag av samme bånd folge umiddelbart efter hverandre også på overgangsstedet.
Ved den beskrevne fremgangsmåte oppnås en intim overlapping av spordelens og boylens isolasjoner på overgangsstedet mellom de to isolasjoner. Det kan således opprettes en gjennomgående isolasjon for spordelen og viklehodet av statorviklingers staver eller spoler selv om det benyttes forskjelligartede båndisolasjoner for de to deler.

Claims (3)

  1. Fremgangsmåte for isolering av staver eller spoler i hoyspenningsstatorviklinger som såvel i spordelen som i viklingshodedelen er forsynt med båndisolasjon, karakterisert ved at vekselvis er lederbuntens spordel henholdsvis hodedel omviklet med et sjikt av en adskilt båndisolasjon for innbyrdes forskyvning av overgangsstedet mellom de to isolasjoner fra sjikt til sjikt.
  2. 2. Fremgangsmåte som angitt i krav 1, karakterisert ved at det for de to isoleringer anvendes bånd med forskjellige tykkelser.
  3. 3. Fremgangsmåte som angitt i krav 1, karakterisert ved at det for de to isoleringer anvendes bånd med samme tykkelse.
NO851695A 1984-04-30 1985-04-29 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater. NO164097C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/605,510 US4560690A (en) 1984-04-30 1984-04-30 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents

Publications (3)

Publication Number Publication Date
NO851695L NO851695L (no) 1985-10-31
NO164097B true NO164097B (no) 1990-05-21
NO164097C NO164097C (no) 1990-08-29

Family

ID=24423963

Family Applications (1)

Application Number Title Priority Date Filing Date
NO851695A NO164097C (no) 1984-04-30 1985-04-29 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater.

Country Status (26)

Country Link
US (1) US4560690A (no)
EP (1) EP0161841B1 (no)
JP (1) JPS60239474A (no)
KR (1) KR870000925B1 (no)
AR (1) AR241784A1 (no)
AU (1) AU554271B2 (no)
CA (1) CA1262352A (no)
CS (2) CS248750B2 (no)
DD (1) DD233374A5 (no)
DE (1) DE3571618D1 (no)
DK (1) DK165693C (no)
EG (1) EG17391A (no)
ES (2) ES8605511A1 (no)
FI (1) FI81096C (no)
GR (1) GR851020B (no)
HU (1) HU198300B (no)
IL (1) IL75038A (no)
IN (1) IN165501B (no)
NO (1) NO164097C (no)
NZ (1) NZ211909A (no)
PH (1) PH21824A (no)
PL (2) PL146070B1 (no)
PT (1) PT80361B (no)
SU (2) SU1380614A3 (no)
YU (2) YU43977B (no)
ZA (1) ZA853161B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986003203A1 (en) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Thienylthiazole derivatives
US5001138B1 (en) * 1985-02-04 1998-01-20 Bayer Agrochem Kk Heterocyclic compounds
EP0192060B1 (de) * 1985-02-04 1991-09-18 Nihon Bayer Agrochem K.K. Heterocyclische Verbindungen
DE3772301D1 (de) * 1986-08-29 1991-09-26 Pfizer 2-guanidino-4-aryl-thiazole fuer die behandlung von peptischen geschwueren.
US4997981A (en) * 1986-10-29 1991-03-05 Pfizer Inc. Processes for 2-(1-pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl) thiazole and analogs
US4997949A (en) * 1986-10-29 1991-03-05 Pfizer Inc. Crystalline 2-(1-pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl) thiazole dihydrochloride trihydrate
DE3750023T2 (de) * 1986-10-29 1994-09-29 Pfizer, Inc., New York, N.Y. Verfahren zur Herstellung von 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)Thiazol und dessen kristallinisches Dihydrochlorid-Trihydrat.
DE3715704A1 (de) * 1987-05-12 1988-11-24 Bayer Ag Ss-fluoracyl-ss-halogenvinylalkylether
ES2030974T3 (es) * 1988-07-21 1992-11-16 Pfizer Inc. Proceso de preparado de sustitutos de guaniltioureas.
IL91152A0 (en) * 1988-08-15 1990-03-19 Fujisawa Pharmaceutical Co Furylthiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
WO1990002127A1 (en) * 1988-08-30 1990-03-08 Pfizer Inc. Hemiphosphate hemihydrate of 2-(1-pentyl-3-guanidino-4-imidazolyl)thiazole
GB8903592D0 (en) * 1989-02-16 1989-04-05 Boots Co Plc Therapeutic agents
IL95548A0 (en) * 1989-09-15 1991-06-30 Fujisawa Pharmaceutical Co Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
US4985402A (en) * 1990-04-25 1991-01-15 International Flavors & Fragrances Inc. 2-Methyl-1-nitrilo-2-methyl -1-hydroxylamino-3-(methoxyphenyl) propane, organoleptic uses thereof and processes for preparing same
US5387656A (en) * 1990-07-23 1995-02-07 Alliedsignal Inc. Substituted cyanoguanidines as curing agents for epoxy resins
EP0564479A1 (en) * 1990-12-24 1993-10-13 Gesellschaft für Biotechnologische Forschung mbH (GBF) Thiangazole, its preparation, compositions and use thereof
US5610038A (en) * 1990-12-24 1997-03-11 Ciba-Geigy Corporation Thiangazole, its preparation, compositions and use thereof
US5387597A (en) * 1991-02-25 1995-02-07 Pfizer Inc. Hemiphosphate hemihydrate of 2-(1-pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)thiazole
CA2105981A1 (en) * 1991-03-13 1992-09-14 Hisashi Takasugi Thiazole derivatives
JPH08506353A (ja) * 1993-06-15 1996-07-09 フアイザー・インコーポレイテツド ウシもしくはブタの細菌感染における免疫刺激剤としてのｈ２−拮抗剤
DK0706514T3 (da) * 1993-08-24 1999-08-02 Medivir Ab Forbindelser og fremgangsmåder til inhibering af HIV og relaterede vira
DE19523658A1 (de) * 1995-06-29 1997-01-02 Bayer Ag Substituierte N-Methylenthioharnstoffe
SI0928793T1 (en) * 1998-01-02 2002-10-31 F. Hoffmann-La Roche Ag Thiazole derivatives
DE102004008141A1 (de) * 2004-02-19 2005-09-01 Abbott Gmbh & Co. Kg Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
US8895564B2 (en) 2010-12-02 2014-11-25 Nihon University Biguanide derivative compound
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2455807A (en) * 1945-09-11 1948-12-07 American Cyanamid Co Preparation of substituted cyanoguanidine
IL49528A (en) * 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
EP0003640B1 (en) * 1978-01-18 1982-01-27 Imperial Chemical Industries Plc Antisecretory guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
JPS6056143B2 (ja) * 1979-08-02 1985-12-09 山之内製薬株式会社 アミジン誘導体ならびにその製造法
GR71929B (no) * 1979-11-13 1983-08-19 Ici Ltd
US4374843A (en) * 1980-10-14 1983-02-22 Pfizer Inc. 2-Guanidino-4-heteroarylthiazoles
US4435396A (en) * 1982-05-10 1984-03-06 Pfizer Inc. Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor

Also Published As

Publication number Publication date
AU554271B2 (en) 1986-08-14
NO851695L (no) 1985-10-31
PT80361A (en) 1985-05-01
YU114587A (en) 1988-02-29
ES8606336A1 (es) 1986-04-01
ZA853161B (en) 1986-12-30
SU1380614A3 (ru) 1988-03-07
DD233374A5 (de) 1986-02-26
FI851683L (fi) 1985-10-31
US4560690A (en) 1985-12-24
KR870000925B1 (ko) 1987-05-07
ES8605511A1 (es) 1986-03-16
CS248750B2 (en) 1987-02-12
NO164097C (no) 1990-08-29
PL253107A1 (en) 1986-06-03
PL257845A1 (en) 1986-10-07
YU44632B (en) 1990-10-31
PL146070B1 (en) 1988-12-31
CA1262352A (en) 1989-10-17
PT80361B (pt) 1987-10-20
NZ211909A (en) 1988-03-30
PH21824A (en) 1988-03-04
IL75038A0 (en) 1985-08-30
AR241784A1 (es) 1992-12-30
IN165501B (no) 1989-11-04
GR851020B (no) 1985-11-25
HUT37787A (en) 1986-02-28
DK165693B (da) 1993-01-04
JPS6316387B2 (no) 1988-04-08
PL145213B1 (en) 1988-08-31
DK190885A (da) 1985-10-31
FI851683A0 (fi) 1985-04-29
AU4179085A (en) 1985-11-07
JPS60239474A (ja) 1985-11-28
EP0161841B1 (en) 1989-07-19
SU1400508A3 (ru) 1988-05-30
KR850007263A (ko) 1985-12-02
HU198300B (en) 1989-09-28
EP0161841A1 (en) 1985-11-21
DK190885D0 (da) 1985-04-29
FI81096C (fi) 1990-09-10
ES548073A0 (es) 1986-04-01
EG17391A (en) 1992-12-30
YU72385A (en) 1988-02-29
DK165693C (da) 1993-06-07
FI81096B (fi) 1990-05-31
CS248741B2 (en) 1987-02-12
IL75038A (en) 1988-07-31
YU43977B (en) 1990-02-28
ES542703A0 (es) 1986-03-16
DE3571618D1 (de) 1989-08-24

Similar Documents

Publication Publication Date Title
NO164097B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater.
US20060272847A1 (en) Superconductor cable
NO158836B (no) Undervannskabel for fremfoering av elektrisk energi, fremgangsmaate for dens fremsilling og pakningsmaterial for anvendelse i kabelen.
CN1734874B (zh) 电力电缆等直径连接器及其制造工艺
JPH08242561A (ja) 発電的な機械のための導体ロッドを製作するための方法と装置
US4653178A (en) Method for the manufacture of a layer winding
SE7906117L (sv) Sasom skiktlindning utbildad transformatorlindning och forfarande for framstellning av en sadan skiktlindning
US2442193A (en) Joint for electric cables
US3946348A (en) Radiation resistant ducted superconductive coil
CA1176704A (en) High-voltage transformer
US2149771A (en) Electric cable
JPS5814592Y2 (ja) 高直列容量変圧器巻線
JPH0346419Y2 (no)
SU1080239A1 (ru) Обмотка статора электрической машины и способ ее изготовлени
SU1039403A1 (ru) Способ изготовлени сверхпровод щего соленоида
US3454804A (en) Insulation of bar type conductor coils of high-voltage stator windings
GB1103764A (en) Improvements in or relating to composite conductors for heavy current windings
DE878387C (de) Biegsames Hochspannungskabel
DE2443398C3 (de) Kabel, dessen Isolierung aus vielen Schichten Papierband besteht
JPH0542203B2 (no)
SU522834A3 (ru) Стержень обмотки электрической машины большой мощности
JPS6127164Y2 (no)
JPS5828108A (ja) Ｏｆケ−ブル
US2519133A (en) Conductor insulation
DE3346170A1 (de) Querwassersperre im muffenbereich elektrischer hochspannungskabel